View Item 

Show simple item record

Insights into Novel Supramolecular Complexes of Two Solid Forms of Norfloxacin and β ‐Cyclodextrin

dc.contributor.authorChattah, Ana K.en_US
dc.contributor.authorMroue, Kamal H.en_US
dc.contributor.authorPfund, Laura Y.en_US
dc.contributor.authorRamamoorthy, Ayyalusamyen_US
dc.contributor.authorLonghi, Marcela R.en_US
dc.contributor.authorGarnero, Claudiaen_US
dc.date.accessioned2013-10-02T15:13:16Z
dc.date.available2014-11-03T16:20:37Zen_US
dc.date.issued2013-10en_US
dc.identifier.citationChattah, Ana K.; Mroue, Kamal H.; Pfund, Laura Y.; Ramamoorthy, Ayyalusamy; Longhi, Marcela R.; Garnero, Claudia (2013). "Insights into Novel Supramolecular Complexes of Two Solid Forms of Norfloxacin and β ‐Cyclodextrin." Journal of Pharmaceutical Sciences 102(10): 3717-3724. <http://hdl.handle.net/2027.42/100136>en_US
dc.identifier.issn0022-3549en_US
dc.identifier.issn1520-6017en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/100136
dc.publisherWiley‐VCH Verlag GmbH & Coen_US
dc.subject.otherNorfloxacinen_US
dc.subject.otherSolid State NMRen_US
dc.subject.otherX ‐Ray Diffractometryen_US
dc.subject.otherFTIRen_US
dc.subject.otherCharacterizationen_US
dc.subject.otherComplexationen_US
dc.subject.otherCyclodextrinsen_US
dc.subject.otherPolymorphismen_US
dc.titleInsights into Novel Supramolecular Complexes of Two Solid Forms of Norfloxacin and β ‐Cyclodextrinen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/100136/1/jps23683.pdf
dc.identifier.doi10.1002/jps.23683en_US
dc.identifier.sourceJournal of Pharmaceutical Sciencesen_US
dc.identifier.citedreferenceDua K, Ramana MV, Singh Sara UV, Himaja M, Agrawal A, Garg V, Pabreja K. 2007. Investigation of enhancement of solubility of norfloxacin β‐cyclodextrin in presence of acidic solubilizing additives. Curr Drug Deliv 4: 21 – 25.en_US
dc.identifier.citedreferenceArredondo‐García JL, Figueroa‐Damián R, Rosas A, Jáuregui A, Corral M, Costa A, Merlos RM, Ríos‐Fabra A, Amábile‐Cuevas CF, Hernández‐Oliva GM, Olguín J, Cardeñosa‐Guerra O. 2004. Comparison of short‐term treatment regimen of ciprofloxacin versus long‐term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open‐label, prospective study. J Antimicrob Chemother 54: 840 – 843.en_US
dc.identifier.citedreferenceLindenberg M, Kopp S, Dressman JB. 2004. Classification of orally administered drugs on the W orld H ealth O rganization model list of essential medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58: 265 – 278.en_US
dc.identifier.citedreferenceOlivera ME, Bistoni A, Anun H, Salinas A, Manzo RH. 2004. Ototopical ciprofloxacin in a glycerin vehicle for the treatment of acute external otitis. Ear Nose Throat J 83: 625 – 638.en_US
dc.identifier.citedreferenceBarbas R, Martí F, Prohens R, Puigjaner C. 2006. Polymorphism of norfloxacin: Evidence of the enantiotropic relationship between polymorphs A and B. Cryst Growth Des 6: 1463 – 1467.en_US
dc.identifier.citedreferencePuigjaner C, Barbas R, Portell A, Font‐Bardia M, Alcobé X, Prohens R. 2010. Revisiting of the solid state of norfloxacin. Cryst Growth Des 10: 2948 – 2953.en_US
dc.identifier.citedreferenceBarbas R, Prohens R, Puigjaner C. 2007. A new polymorph of norfloxacin. J Therm Anal Cal 89: 687 – 692.en_US
dc.identifier.citedreferenceBrewster ME, Loftsson TT. 2007. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 59: 645 – 666.en_US
dc.identifier.citedreferenceCorralo Spada J, Zapata Noreña CP, Ferreira Marczak LD, Tessaro IC. 2012. Study on the stability of β‐carotene microencapsulated with pinhão ( A raucaria angustifolia seeds) starch. Carbohyd Polym 89: 1166 – 1173.en_US
dc.identifier.citedreferenceMunoz‐Celaya AL, Ortiz‐García M, Vernon‐Carter EJ, Jauregui‐Rincón J, Galindo E, Serrano‐Carreón L. 2012. Spray‐drying microencapsulation of T richoderma harzianum conidias in carbohydrate polymers matrices. Carbohyd Polym 88: 1141 – 1148.en_US
dc.identifier.citedreferenceGarnero C, Chattah AK, Longhi M. 2013. Supramolecular complexes of maltodextrin and furosemide polymorphs: A new approach for delivery systems. Carbohyd Polym 94: 292 – 300.en_US
dc.identifier.citedreferenceZoppi A, Garnero C, Garro Linck Y, Chattah AK, Monti GA, Longhi M. 2011. Enalapril:β‐ CD complex: Stability enhancement in solid state. Carbohyd Polym 86: 716 – 721.en_US
dc.identifier.citedreferencePham TN, Watson SA, Edwards AJ, Chavda M, Clawson JS, Strohmeier M, Vogt FG. 2010. Analysis of amorphous solid dispersions using 2 D solid‐state NMR and 1 H T 1 relaxation measurements. Mol Pharm 7: 1667 – 1691.en_US
dc.identifier.citedreferenceVogt FG, Strohmeier M. 2012. 2 D solid‐state NMR analysis of inclusion in drug−cyclodextrin complexes. Mol Pharm 9: 3357 – 3374.en_US
dc.identifier.citedreferenceFawaz F, Bonini F, Guyot M, Bildet J, Maury M, Lagueny AM. 1996. Bioavailability of norfloxacin from PEG 6000 solid dispersion and cyclodextrin inclusion complexes in rabbits. Int J Pharm 132: 271 – 275.en_US
dc.identifier.citedreferenceTorres‐Labandeira JJ, de Labra Pinon P, Perez‐Marcos B, Alvarez‐Lorenzo C, Vila‐Jato JL. 1998. Effect of norfloxacin complexation with β‐cyclodextrin on the in vitro dissolution behaviour and its interaction with M g2+ and A l3+. J Thermal Anal Calorim 51: 1009 – 1021.en_US
dc.identifier.citedreferenceByrn SR, Pfeiffer RR, Stowell JG, Eds. 1999. Solid state chemistry of drugs. 2nd ed. SSCI, Inc.West Lafayette, Indianaen_US
dc.identifier.citedreferenceBugay DE. 2001. Characterization of the solid‐state: Spectroscopic techniques. Adv Drug Deliv Rev 48: 43 – 65.en_US
dc.identifier.citedreferenceHarris RK. 1994. Nuclear magnetic resonance spectroscopy. London: Logman Scientific and Technical.en_US
dc.identifier.citedreferenceHarris RK. 2007. Applications of solid‐state NMR to pharmaceutical polymorphism and related matters. J Pharm Pharmacol 59: 225 – 239.en_US
dc.identifier.citedreferenceGeppi M, Mollica G, Borsacchi S, Veracini CA. 2008. Solid‐state NMR studies of pharmaceutical systems. Appl Spectrosc Rev 43: 202 – 302.en_US
dc.identifier.citedreferenceNishiyama Y, Frey MH, Musaka S, Utsumi H. 2010. 13 C solid‐state NMR chromatography by magic angle spinning 1 H T 1 relaxation ordered spectroscopy. J Magn Reson 202: 135 – 139.en_US
dc.identifier.citedreferenceMroue KH, MacKinnon N, Xu J, Zhu P, McNerny E, Kohn DH, Morris MD, Ramamoorthy A. 2012. High‐resolution structural insights into bone: A solid‐state NMR relaxation study utilizing paramagnetic doping. J Phys Chem B 116: 11656 – 11661.en_US
dc.identifier.citedreferenceKhitrin AK, Fujiwara T, Akutsub H. 2003. Phase‐modulated heteronuclear decoupling in NMR of solids. J Magn Reson 162: 46 – 53.en_US
dc.identifier.citedreferenceChongcharoen W, Byrn SR, Sutanthavibul N. 2008. Solid state interconversion between anhydrous norfloxacin and its hydrates. J Pharm Sci 97: 473 – 489.en_US
dc.identifier.citedreferenceGuyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. 1995. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and PEG solid dispersions. Int J Pharm 123: 53 – 63.en_US
dc.identifier.citedreferenceWalsh RDB, Bradner MW, Fleischman S, Morales LA, Moulton B, Rodriguez‐Hornedo N, Zaworotko M. 2003. Crystal engineering of the composition of pharmaceutical phases. Chem Commun 2: 186 – 187.en_US
dc.identifier.citedreferenceRemenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee M, Guzman HR, Almarsson O. 2003. Crystal engineering of novel cocrystals of a triazole drug with 1,4‐dicarboxylic acids. J Am Chem Soc 125: 8456 – 8457.en_US
dc.identifier.citedreferenceLutker KM, Quiñones R, Xu J, Ramamoorthy A, Matzger AJ. 2011. Polymorphs and hydrates of acyclovir. J Pharm Sci 100: 949 – 963.en_US
dc.identifier.citedreferenceHilfiker R, Ed. 2006. Polymorphism in the pharmaceutical industry. Germany: Wiley‐VCH Verlag GmbH & Co.en_US
dc.identifier.citedreferenceMazuel C. 1991. In Analytical profiles of drug substances; Norfloxacin Florey K, Ed. Vol. 20. San Diego: Academic Press, pp 557 – 600.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jps23683.pdf
Size:
1.478MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.